Effect of Surface-Modified Paclitaxel Nanowires on U937 Cells In Vitro: A Novel Drug Delivery Vehicle

Figure 6

(a, b, c) Total number of U937 cells with different paclitaxel forms after 24, 48, and 72 h, respectively. Dotted line represents the initial number of cells (1.8×10⁶). (d, e, f) % cell proliferation with different paclitaxel forms after 24, 48, and 72 h, respectively. Incept: expanded view of the paclitaxel region. (g, h, i) % nonviable cells at 24, 48, and 72 h, respectively.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)